Lung cancer trial aims to crack the code of treatment resistance
NCT ID NCT02314481
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study looked at 50 people with non-small cell lung cancer to understand why tumors sometimes stop responding to therapy. Researchers analyzed genetic differences within each tumor and tested various treatments, including immunotherapy and targeted drugs. The goal was to find markers that predict response and help design better future trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Univeristy College London Hospital
London, United Kingdom
Conditions
Explore the condition pages connected to this study.